openPR Logo
Press release

Hemoglobinopathies Market Driven by Extensive Research and Development Activities

05-11-2016 02:39 PM CET | Health & Medicine

Press release from: Transparency Market Research

Hemoglobinopathies Market Driven by Extensive Research

Global Hemoglobinopathies Market: Description

The U.S. National Library of Medicine defines hemoglobinopathy as a group of disorders passed down from one generation to another that are characterized by an abnormal structure or production of the hemoglobin molecule. Hemoglobinopathy disorders include sickle cell anemia, hemoglobin C disease, hemoglobin S-C disease, and various forms of thalassaemia. The growing prevalence of hemoglobinopathy disorders, particularly sickle cell anemia, has boosted the growth of the global hemoglobinopathies market.

Browse Full Report : http://www.transparencymarketresearch.com/hemoglobinopathies-market.html

Though the prevalence of hemoglobinopathies is high across under-developed economies, including countries in Southeast Asia and the Sub-Saharan region, the global hemoglobinopathies market is expected to grow across developed and developing economies in North America and Asia Pacific, respectively, due to better health care infrastructure. The introduction of advanced diagnostics and therapeutics will likely boost the growth of the market in the coming years. Genetic testing, blood testing, pre-implantation genetic diagnosis, prenatal genetic testing, and hemoglobin electrophoresis are some of the key diagnostics for identifying hemoglobinopathies disorders. Iron chelation therapy, blood transfusion, hydroxyurea, and bone marrow transplant are the common therapies available in the market. Research and development activities and regulatory support are shaping the future of the global hemoglobinopathies market.

Global Hemoglobinopathies Market: Overview

Among various hemoglobinopathy disorders, sickle cell anemia is the most common inherited blood disease. According to the World Health Organization (WHO), around 5% of the world’s population carries trait genes for hemoglobinopathy disorders such as thalassaemia and sickle cell anemia. While sickle cell anemia is most common across Africa, various forms of thalassaemia are prevalent in the Middle East, the Mediterranean basin, and Asia. In sickle cell disease, the half-moon shape of red blood cells causes poor blood oxygen levels and blood vessel blockages. This leads to anemia among the patients.

The rapid rise in the number of people affected by the disease has led governments and regulatory authorities to initiate awareness programs to decrease hemoglobinopathy-related mortality rates. For example, in 2010, the Centers for Disease Control and Prevention (CDC) started the Thalassaemia Data Collection Project and Blood Safety Monitoring. All these factors are expected to positively impact the growth of the global hemoglobinopathies market.

Further, the increased awareness about genetic testing for diagnosis of sickle cell anemia and other hemoglobinopathy disorders is anticipated to contribute significantly toward the growth of the market in the near future. Genetic testing has emerged as the most cost-effective strategy to reduce the prevalence of hemoglobinopathy disorders.

Global Hemoglobinopathies Market: Region-wise Outlook

The global hemoglobinopathies market has been segmented into four key regions: Asia Pacific, Europe, North America, and Rest of the World. Sickle cell anemia is most common in Central and West Africa where about 25% of the population has sickle cell trait and around 1%-2% of all babies are born with a form of the disease. In North America, particularly in the U.S., where the population is estimated to be over 270 million, around 1,000 babies are born with sickle cell disease every year. The growing prevalence of various hemoglobinopathy disorders, along with a high level of awareness about hemoglobinopathy-related genetic testing has propelled the growth of the hemoglobinopathies market in North America. However, in the coming years, improving health care infrastructure in Asia Pacific and introduction of low-cost diagnostic alternatives are projected to boost the growth of the market in the region.

Request A Sample Of This Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=10676

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:
•Market segments and sub-segments
•Market trends and dynamics
•Supply and demand
•Market size
•Current trends/opportunities/challenges
•Competitive landscape
•Technological breakthroughs
•Value chain and stakeholder analysis
T
he regional analysis covers:
•North America (U.S. and Canada)
•Latin America (Mexico, Brazil, Peru, Chile, and others)
•Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries,

Belgium, Netherlands, Luxembourg)
•Eastern Europe (Poland, Russia)
•Asia Pacific (China, India, Japan, ASEAN, Australia and New Zealand)
•Middle East and Africa (GCC, Southern Africa, North Africa)

About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact us:
Mr. Sudip S
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email:Â sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hemoglobinopathies Market Driven by Extensive Research and Development Activities here

News-ID: 340541 • Views:

More Releases from Transparency Market Research

Europe Anti-slip Paper Market Valuation Set to Reach USD 450.1 Million by 2035, Expanding at a CAGR of 7.0%
Europe Anti-slip Paper Market Valuation Set to Reach USD 450.1 Million by 2035, …
The Europe Anti-slip Paper Market is poised for robust growth over the forecast period, driven by rising demand for sustainable, efficient, and safe packaging solutions across industries. Valued at US$ 214.4 Mn in 2024, the market is projected to almost double and touch US$ 450.1 Mn by 2035, registering a CAGR of 7.0% from 2025 to 2035. This growth is supported by stringent regulatory frameworks, the rapid expansion of e-Commerce,
Ethyl Acetate Market Outlook 2035: Global Valuation to Reach USD 15.1 Billion Amid Rising Demand for Green Solvents and Flexible Packaging
Ethyl Acetate Market Outlook 2035: Global Valuation to Reach USD 15.1 Billion Am …
The global ethyl acetate market is entering a phase of sustained expansion driven by strong industrial demand and accelerating adoption of green, sustainable solvents. Valued at US$ 6.5 Bn in 2024, the market is projected to expand at a CAGR of 8.0% from 2025 to 2035, ultimately reaching US$ 15.1 Bn by 2035. This growth reflects rising use across paints and coatings, adhesives, pharmaceuticals, packaging, and the food & beverage
HPLC Column Market Outlook 2035: Global Industry to Reach USD 4.7 Billion by 2035, Expanding at 5.3% CAGR
HPLC Column Market Outlook 2035: Global Industry to Reach USD 4.7 Billion by 203 …
The global HPLC Column Market is poised for steady and sustained growth through 2035, supported by rising demand for analytical testing across pharmaceutical, biotechnology, food and beverages, and environmental sectors. Valued at US$ 2.6 Bn in 2024, the industry is projected to reach US$ 4.7 Bn by 2035, expanding at a CAGR of 5.3% from 2025 to 2035. Increasing regulatory compliance, technological advancements in column design, and growing applications in
Carboxylic Acid Market Outlook 2035: Global Market to Reach USD 12.9 Billion by 2035, Expanding at 6.3% CAGR
Carboxylic Acid Market Outlook 2035: Global Market to Reach USD 12.9 Billion by …
The global carboxylic acid market continues to gain momentum as demand surges across diverse industrial applications. Valued at US$ 6.6 Bn in 2024, the market is projected to expand at a CAGR of 6.3% between 2025 and 2035, ultimately reaching US$ 12.9 Bn by 2035. This strong growth trajectory is driven by the rising consumption of carboxylic acids in chemicals, food and beverages, pharmaceuticals, agriculture, personal care, and industrial manufacturing.

All 5 Releases


More Releases for Hemoglobinopathies

Genetic Inheritance Driving Growth in Hemoglobinopathies Treatment Market: A Key …
The Hemoglobinopathies Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Current Hemoglobinopathies Treatment Market Size and Its Estimated Growth Rate? The hemoglobinopathies treatment market has experienced strong growth in recent years. It will increase from $9.01 billion in 2024 to $9.94 billion
Hemoglobinopathies Market Future Prediction Report By 2032
​​​In 2023, the global hemoglobinopathies market was valued at approximately USD 9.11 billion. Projections indicate that by 2032, the market will reach around USD 26.72 billion, reflecting a compound annual growth rate (CAGR) of 12.7% from 2024 to 2032. Hemoglobinopathies Market Overview The hemoglobinopathies market is experiencing significant growth due to the increasing prevalence of genetic disorders such as sickle cell disease and thalassemia. Advancements in diagnostic techniques, including genetic testing and
Genetic Inheritance Driving Growth in Hemoglobinopathies Treatment Market Driver …
How Is the Hemoglobinopathies Treatment Market Projected to Grow, and What Is Its Market Size? The market size for hemoglobinopathies treatment has witnessed significant expansion in the preceding years. It is expected to enlarge from a value of $9.01 billion in 2024 to $9.94 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 10.3%. The considerable growth during the historical period is credited to factors such as scientific breakthroughs,
North America Hemoglobinopathies Market Report Analysis 2032
1. Introduction Definition and Overview of Hemoglobinopathies Hemoglobinopathies are a group of inherited disorders characterized by abnormal production or structure of hemoglobin, the protein in red blood cells responsible for carrying oxygen throughout the body. The most common types include sickle cell anemia and thalassemia, which can lead to severe health complications such as anemia, pain, and organ damage. Importance of Studying Hemoglobinopathies Market in North America Studying the hemoglobinopathies market in North America
Hemoglobinopathies Treatment Market Size and Forecast to 2033
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033. Hemoglobinopathies Treatment Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance. The Market Size Is Expected To Reach $13.2 billion In 2028 At
Europe Hemoglobinopathies Market Size & Forecast, 2024-2032
The European hemoglobinopathies market is on the cusp of significant expansion, driven by a combination of technological advancements, increased awareness, and strategic initiatives. Hemoglobinopathies, which include disorders such as sickle cell disease and thalassemia, pose considerable public health challenges across Europe. This comprehensive analysis will explore market trends, segmentation, growth factors, recent developments, competitor landscape, key players, and provide answers to frequently asked questions, culminating in a detailed look at